AGP Executive Report
Last update: 12 hours agoHair Loss & TCM: A review highlights Polygonum multiflorum, a thousand-year-old Traditional Chinese Medicine root, as a potential safer hair-loss option by targeting DHT and protecting follicle cells—though researchers stress more high-quality human trials are needed. Gut Health & Fermentation: A new write-up points to sauerkraut’s lactic-acid bacteria as a gut-barrier friendly food, citing research that fermented cabbage may outperform raw cabbage and some probiotic supplements. Emergency Care Tech: A scoping review of 114 studies finds AI is spreading across cardiac arrest care—from early prediction to resuscitation support and post-event planning—while calling for stronger real-world testing before broad rollout. Drug Regulation in China: China’s NMPA granted IND clearance for Adcentrx Therapeutics’ STEAP1 ADC (ADRX-0405) for late-stage solid tumors, including prostate cancer. Autoimmune Treatment Update: Telitacicept received NMPA approval for Sjögren’s disease, with additional approvals reported for IgA nephropathy. Healthcare Policy Watch: Hong Kong announced a two-month consultation starting June 15 on its first five-year blueprint, expected to cover healthcare among other sectors. Market Signals (Wellness Demand): Multiple industry forecasts project rapid growth for dietary supplements, probiotic skincare, and the global saffron market—fuelled by wellness, beauty, and preventive health trends.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.